Dermatologicals in Algeria
DERMATOLOGICALS IN ALGERIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
the Category Is Set To Register Healthy Growth Over the Forecast Period
Dermatologicals Is Projected To Post Slower Growth Over the Forecast Period
Sociocultural Factors Affect Sales in Different Ways
Competitive Landscape
Saidal Algerie SpA Is Leading the Category
International Brands Lead the Category
There Is An Absence of Generics Production in Dermatologicals
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Growth Is Slowing Down Due To Economic Hardship
Increasing Domestic Production Is Promoted by the Algerian Government
Local Producers of Generics Continue Increasing Their Share in 2018
Consumer Health Products Are Sold Almost Exclusively in Chemists/pharmacies
Consumer Health Is Expected To Perform Positively Over the Forecast Period
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
Dermatologicals is projected to continue registering a healthy value sales performance in the forecast period, due to growing urbanisation and changing consumer habits. More consumers are interested in buying dermatologicals, particularly categories perceived more as cosmetics such as hair loss treatments and medicated shampoos. Additionally, dermatologicals is set to continue being supported by rising consumer-awareness and frequent new product developments. Also, the emergence of paediatric de...
Euromonitor International's Dermatologicals in Algeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.